Crystal Formulation Services, a member of Crystal Pharmatech

Established in July 2021, Crystal Formulation Services (CFS) is a wholly-owned subsidiary of Crystal Pharmatech, located in Suzhou, China. Our mission is to offer a comprehensive range of services, including pre-formulation study, formulation development, GMP manufacturing, clinical supply, and regulatory support for innovative drug products around the world. Committed to being a trusted partner, we prioritize delivering the highest quality deliverables through sound science and operational excellence. Our core values revolve around patient first, meeting customers’ needs, protecting clients’ IP and property, ensuring quality and upholding scientific excellence. Our formulation development platforms include conventional formulation, bioavailability enhancement formulation, and pediatric formulation (mini-tablet). Some highlights of our formulation capabilities: - Conventional formulation technology for tablets (including bilayer), capsules and sachet - Bioavailability enhancement formulation with expertise in amorphous solid dispersion through spray drying, hot melt extrusion, etc. - Pediatric formulation, specializing in mini-tablet development Our competitive edge stems from various factors: - A strong technical team with over 20 years of experience of delivering more than 100 early phase and 16 commercialized products globally - Top-of-the-line equipment/instruments for DS/DP characterization and formulation technology - A one-stop-shop from preclinical development to commercial manufacturing - Integrated clinical formulation development process from bulk manufacturing to packaging and supply - GMP facility and quality system that meets NMPA, FDA, and EMA requirements At CFS, we are fully dedicated to providing unparalleled formulation services to our partners across the world. We'd like to hear your questions and encourage you to visit our facilities in Suzhou. Your trust is our commitment, and we look forward to the opportunity to collaborate with you.